Complete FDA and NHTSA recall records dated in 2025, organized for browsing by month, category and recalling company.
Select a month to review the recall records reported during that period.
Records are ordered by the best available source date.
Defective Container - A defect in the side-seal which allows leakage of product.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Labeling: Not Elsewhere Classified:Incorrect RFID tag labels applied to product by repackaging firm.
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
foreign objects (black plastic planting material) in granulated onion
Product may be contaminated with E. coli O7:K1 (IAI39/ExPEC) and E. coli 1303
Undeclared wheat.
Undeclared Soy. The firm received positive test results for soy which is not listed on the label. The firm also noticed that the amount of boron in the product is listed as 250mg per…
Potential metal fragments from supplier raw material (downstream recall)
foreign objects (black plastic planting material) in granulated onion
The 3oz. sealed packet of Caesar Dressing in Costco Chicken Sandwich w/ Caesar Salad may contain plastic material.
Undeclared Sulfite. Shrimp may contain 3.4mg Sulfur Dioxide per serving and label does not declare Sulfite.
Product is mislabeled - the labeling contains incorrect ingredient information and fails to declare milk as an allergen
Undeclared Soy
Potential metal fragments from supplier raw material (downstream recall)
Potential contamination with Listeria monocytogenes.
Potential metal fragments from supplier raw material (downstream recall)
Potential to be contaminated with Clostridium botulinum. Products manufactured without an approved process filed.
BMW of North America, LLC (BMW) is recalling certain 2026 X6, X7, X5, and X5 Plug-In Hybrid vehicles. The instrument panel may have been manufactured incorrectly and prevent the…
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.
